{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:20:02Z","timestamp":1793823602598,"version":"4.6.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["AICO\/2019\/250"],"award-info":[{"award-number":["AICO\/2019\/250"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["Gent T CDEI-04\/20-A"],"award-info":[{"award-number":["Gent T CDEI-04\/20-A"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["PROMETEO\/2019\/032"],"award-info":[{"award-number":["PROMETEO\/2019\/032"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00209"],"award-info":[{"award-number":["PI18\/00209"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["SAF2017-89714-R"],"award-info":[{"award-number":["SAF2017-89714-R"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.biocel.2021.106066","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T11:42:49Z","timestamp":1629718969000},"page":"106066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Primary hypercholesterolemia and development of cardiovascular disorders: Cellular and molecular mechanisms involved in low-grade systemic inflammation and endothelial dysfunction"],"prefix":"10.1016","volume":"139","author":[{"given":"Aida","family":"Collado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Piqueras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Jesus","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.biocel.2021.106066_bib0005","first-page":"389","article-title":"Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities","volume":"16","author":"Back","year":"2019","journal-title":"Nature Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.biocel.2021.106066_bib0010","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.numecd.2019.09.012","article-title":"Platelet function and activation markers in primary hypercholesterolemia treated with anti-PCSK9 monoclonal antibody: A 12-month follow-up","volume":"30","author":"Barale","year":"2020","journal-title":"Nutr Metab Cardiovasc Dis."},{"key":"10.1016\/j.biocel.2021.106066_bib0015","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6508709","article-title":"Simvastatin Effects on Inflammation and Platelet Activation Markers in Hypercholesterolemia","author":"Barale","year":"2018","journal-title":"Biomed Res Int."},{"issue":"3","key":"10.1016\/j.biocel.2021.106066_bib0020","doi-asserted-by":"crossref","first-page":"C422","DOI":"10.1152\/ajpcell.00381.2008","article-title":"Nox4 NADPH oxidase mediates oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells","volume":"296","author":"Basuroy","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol"},{"issue":"4","key":"10.1016\/j.biocel.2021.106066_bib0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tcb.2015.12.002","article-title":"TNF and ROS crosstalk in inflammation","volume":"26","author":"Blaser","year":"2016","journal-title":"Trends Cell. Biol."},{"issue":"2","key":"10.1016\/j.biocel.2021.106066_bib0030","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4330\/wjc.v9.i2.76","article-title":"PCSK9 inhibitors: a new era of lipid lowering therapy","volume":"9","author":"Chaudhary","year":"2017","journal-title":"World J Cardiol."},{"issue":"3","key":"10.1016\/j.biocel.2021.106066_bib0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123088","article-title":"Oxidized low-density lipoprotein contributes to atherogenesis via co-activation of macrophages and mast cells","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One."},{"issue":"12","key":"10.1016\/j.biocel.2021.106066_bib0040","doi-asserted-by":"crossref","first-page":"e0144015","DOI":"10.1371\/journal.pone.0144015","article-title":"Soluble trail concentration in serum is elevated in people with hypercholesterolemia","volume":"10","author":"Cheng","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.biocel.2021.106066_bib0045","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.amjhyper.2006.03.016","article-title":"Relationship of circulating biomarkers of inflammation and hemostasis with preclinical atherosclerotic burden in nonsmoking hypercholesterolemic men","volume":"19","author":"Chironi","year":"2006","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.biocel.2021.106066_bib0050","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fimmu.2018.00294","article-title":"Endothelial to mesenchymal transition represents a key link in the interaction between inflammation and endothelial dysfunction","volume":"9","author":"Cho","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.biocel.2021.106066_bib0055","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8010018","article-title":"Novel immune features of the systemic inflammation associated with primary hypercholesterolemia: changes in cytokine\/chemokine profile, increased platelet and leukocyte activation","volume":"8","author":"Collado","year":"2018","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.biocel.2021.106066_bib0060","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.arcmed.2016.01.002","article-title":"Postprandial changes in chemokines related to early atherosclerotic processes in familial hypercholesterolemic subjects: a preliminary study","volume":"47","author":"Cortes","year":"2016","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.biocel.2021.106066_bib0065","doi-asserted-by":"crossref","first-page":"17093","DOI":"10.1038\/nrdp.2017.93","article-title":"Familial hypercholesterolaemia","volume":"3","author":"Defesche","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"6","key":"10.1016\/j.biocel.2021.106066_bib0070","doi-asserted-by":"crossref","first-page":"737","DOI":"10.5551\/jat.31088","article-title":"hmgb1modulates the treg\/th17 ratio in atherosclerotic patients","volume":"23","author":"Ding","year":"2016","journal-title":"J. Atheroscler. Thromb."},{"issue":"2","key":"10.1016\/j.biocel.2021.106066_bib0075","first-page":"601","article-title":"miR-505-3p controls chemokine receptor up-regulation in macrophages: role in familial hypercholesterolemia","volume":"32","author":"Escate","year":"2018","journal-title":"FASEB J."},{"issue":"11","key":"10.1016\/j.biocel.2021.106066_bib0080","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1089\/ars.2014.5969","article-title":"Combined sub-optimal doses of rosuvastatin and bexarotene impair angiotensin II-induced arterial mononuclear cell adhesion through inhibition of Nox5 signaling pathways and increased RXR\/PPARalpha and RXR\/PPARgamma interactions","volume":"22","author":"Escudero","year":"2015","journal-title":"Antioxid. Redox Signal."},{"issue":"2","key":"10.1016\/j.biocel.2021.106066_bib0085","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.atherosclerosis.2014.10.106","article-title":"Pro-inflammatory monocyte-macrophage polarization imbalance in human hypercholesterolemia and atherosclerosis","volume":"237","author":"Fadini","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biocel.2021.106066_bib0090","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fphar.2018.00055","article-title":"Atherosclerosis is an inflammatory disease which lacks a common anti-inflammatory therapy: how human genetics can help to this issue. a narrative review","volume":"9","author":"Fava","year":"2018","journal-title":"Front Pharmacol."},{"issue":"3","key":"10.1016\/j.biocel.2021.106066_bib0095","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/cvr\/cvv147","article-title":"Monocyte trafficking across the vessel wall","volume":"107","author":"Gerhardt","year":"2015","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.biocel.2021.106066_bib0100","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial cell dysfunction and the pathobiology of atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ. Res"},{"issue":"1","key":"10.1016\/j.biocel.2021.106066_bib0105","doi-asserted-by":"crossref","first-page":"8296","DOI":"10.1038\/s41598-017-08373-4","article-title":"Up-regulation of NADPH oxidase-mediated redox signaling contributes to the loss of barrier function in KRIT1 deficient endothelium","volume":"7","author":"Goitre","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biocel.2021.106066_bib0110","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cyto.2018.10.011","article-title":"Inflammatory biomarkers in patients in Simvastatin treatment: no effect of co-enzyme Q10 supplementation","volume":"113","author":"Hansen","year":"2019","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.biocel.2021.106066_bib0115","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.atherosclerosis.2014.01.022","article-title":"Subjects with familial hypercholesterolemia are characterized by an inflammatory phenotype despite long-term intensive cholesterol lowering treatment","volume":"233","author":"Holven","year":"2014","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.biocel.2021.106066_bib0120","doi-asserted-by":"crossref","first-page":"e1332","DOI":"10.1016\/S2214-109X(19)30318-3","article-title":"World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions","volume":"7","author":"Kaptoge","year":"2019","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.biocel.2021.106066_bib0125","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fpsyt.2019.00103","article-title":"Statins and inflammation: new therapeutic opportunities in psychiatry","volume":"10","author":"Kim","year":"2019","journal-title":"Front. Psychiatry"},{"issue":"1","key":"10.1016\/j.biocel.2021.106066_bib0130","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/ATVBAHA.116.308198","article-title":"Monocyte conversion during inflammation and injury","volume":"37","author":"Kratofil","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"21 Suppl 1","key":"10.1016\/j.biocel.2021.106066_bib0135","first-page":"Ii27","article-title":"Endothelial function: a critical determinant in atherosclerosis?","volume":"109","author":"Landmesser","year":"2004","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.biocel.2021.106066_bib0140","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1586\/14779072.2015.1030395","article-title":"Evolocumab (AMG 145) for primary hypercholesterolemia","volume":"13","author":"Langslet","year":"2015","journal-title":"Expert Rev. Cardiovasc. Ther."},{"issue":"4","key":"10.1016\/j.biocel.2021.106066_bib0145","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/ATVBAHA.108.181610","article-title":"NADPH oxidases: functions and pathologies in the vasculature","volume":"30","author":"Lass\u00e8gue","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.biocel.2021.106066_bib0150","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1161\/01.ATV.13.7.1013","article-title":"Oxidized LDL-induced leukocyte\/endothelium interaction in vivo involves the receptor for platelet-activating factor","volume":"13","author":"Lehr","year":"1993","journal-title":"Arterioscler Thromb."},{"issue":"17","key":"10.1016\/j.biocel.2021.106066_bib0155","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.jacc.2018.08.1043","article-title":"Inflammation, immunity, and infection in atherothrombosis: JACC review topic of the week","volume":"72","author":"Libby","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.biocel.2021.106066_bib0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/jama.2018.4242","article-title":"Nontraditional risk factors in cardiovascular disease risk assessment: updated evidence report and systematic review for the US preventive services task force","volume":"320","author":"Lin","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.biocel.2021.106066_bib0165","doi-asserted-by":"crossref","DOI":"10.1111\/joim.12758","article-title":"PCSK9 plays a novel immunological role in oxidized LDL-induced dendritic cell maturation and activation of T cells from human blood and atherosclerotic plaque","author":"Liu","year":"2018","journal-title":"J. Inter. Med"},{"issue":"5","key":"10.1016\/j.biocel.2021.106066_bib0170","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1160\/TH07-01-0035","article-title":"Transmembrane chemokines: versatile\u2019 special agents\u2019 in vascular inflammation","volume":"97","author":"Ludwig","year":"2007","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.biocel.2021.106066_bib0175","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.biocel.2021.106066_bib0180","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8050708","article-title":"Systemic inflammation in metabolic syndrome: increased platelet and leukocyte activation, and key role of CX3CL1\/CX3CR1 and CCL2\/CCR2 axes in arterial platelet-proinflammatory monocyte adhesion","volume":"8","author":"Marques","year":"2019","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.biocel.2021.106066_bib0185","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1182\/blood-2007-01-070607","article-title":"A critical role for TNFalpha in the selective attachment of mononuclear leukocytes to angiotensin-II-stimulated arterioles","volume":"110","author":"Mateo","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.biocel.2021.106066_bib0190","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.atherosclerosis.2007.08.014","article-title":"Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients","volume":"197","author":"Mazor","year":"2008","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.biocel.2021.106066_bib0195","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1002\/jcp.26466","article-title":"Oxidative burden in familial hypercholesterolemia","volume":"233","author":"Mollazadeh","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"8","key":"10.1016\/j.biocel.2021.106066_bib0200","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1161\/CIRCRESAHA.109.216036","article-title":"Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium\/calmodulin-dependent, rac-1-independent pathways in human endothelial cells","volume":"106","author":"Montezano","year":"2010","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.biocel.2021.106066_bib0205","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41569-018-0144-3","article-title":"Targeting inflammation in CVD: advances and challenges","volume":"16","author":"Moore","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biocel.2021.106066_bib0210","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3389\/fphar.2018.00707","article-title":"Familial hypercholesterolemia: new horizons for diagnosis and effective management","volume":"9","author":"Mytilinaiou","year":"2018","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.biocel.2021.106066_bib0215","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev-pharmtox-011613-140025","article-title":"Targeting PCSK9 for hypercholesterolemia","volume":"54","author":"Norata","year":"2014","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"10","key":"10.1016\/j.biocel.2021.106066_bib0220","doi-asserted-by":"crossref","first-page":"H1919","DOI":"10.1152\/ajpheart.00910.2011","article-title":"Expression and functional significance of NADPH oxidase 5 (Nox5) and its splice variants in human blood vessels","volume":"302","author":"Pandey","year":"2012","journal-title":"Am. J. Physiol. Heart. Circ. Physiol."},{"issue":"4","key":"10.1016\/j.biocel.2021.106066_bib0225","first-page":"669","article-title":"Familial hypercholesterolemia","volume":"14","author":"Pejic","year":"2014","journal-title":"Ochsner. J."},{"issue":"4","key":"10.1016\/j.biocel.2021.106066_bib0230","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1089\/ars.2008.2231","article-title":"Regulation of NADPH oxidase in vascular endothelium: the role of phospholipases, protein kinases, and cytoskeletal proteins","volume":"11","author":"Pendyala","year":"2009","journal-title":"Antioxid. Redox Signal"},{"issue":"1","key":"10.1016\/j.biocel.2021.106066_bib0235","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12944-017-0470-1","article-title":"Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control study","volume":"16","author":"Rahman","year":"2017","journal-title":"Lipids Health Dis."},{"issue":"2","key":"10.1016\/j.biocel.2021.106066_bib0240","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.metabol.2009.07.026","article-title":"Increased oxidative stress levels and normal antioxidant enzyme activity in circulating mononuclear cells from patients of familial hypercholesterolemia","volume":"59","author":"Real","year":"2010","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.biocel.2021.106066_bib0245","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/ATVBAHA.112.254870","article-title":"Arterial and venous endothelia display differential functional fractalkine (CX3CL1) expression by angiotensin-II","volume":"33","author":"Rius","year":"2013","journal-title":"Arterioscler Thromb Vasc. Biol."},{"issue":"6","key":"10.1016\/j.biocel.2021.106066_bib0250","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11886-019-1130-z","article-title":"Polygenic hypercholesterolemia and cardiovascular disease risk","volume":"21","author":"Sharifi","year":"2019","journal-title":"Curr. Cardiol. Rep."},{"issue":"2","key":"10.1016\/j.biocel.2021.106066_bib0255","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s11883-014-0482-5","article-title":"Familial hypercholesterolemia--epidemiology, diagnosis, and screening","volume":"17","author":"Singh","year":"2015","journal-title":"Curr. Atheroscler. Rep."},{"issue":"19","key":"10.1016\/j.biocel.2021.106066_bib0260","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.jacc.2014.01.060","article-title":"The severe hypercholesterolemia phenotype: clinical diagnosis, management, and emerging therapies","volume":"63","author":"Sniderman","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.biocel.2021.106066_bib0265","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1113\/EP086204","article-title":"NOX5: molecular biology and pathophysiology","volume":"104","author":"Touyz","year":"2019","journal-title":"Exp. Physiol."},{"issue":"4","key":"10.1016\/j.biocel.2021.106066_bib0270","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jamacardio.2019.5954","article-title":"Association of monogenic vs polygenic hypercholesterolemia with risk of atherosclerotic cardiovascular disease","volume":"5","author":"Trinder","year":"2020","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.biocel.2021.106066_bib0275","first-page":"9","article-title":"TNF-\u03b1 in the cardiovascular system: from physiology to therapy","volume":"7","author":"Urschel","year":"2015","journal-title":"Int. J. Interferon Cytokine Mediat. Re."},{"key":"10.1016\/j.biocel.2021.106066_bib0280","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fphys.2014.00294","article-title":"Platelets and their chemokines in atherosclerosis-clinical applications","volume":"5","author":"von Hundelshausen","year":"2014","journal-title":"Front Physiol."},{"issue":"4","key":"10.1016\/j.biocel.2021.106066_bib0285","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1128\/MCB.01393-09","article-title":"Structural insights into Nox4 and Nox2: motifs involved in function and cellular localization","volume":"30","author":"von L\u00f6hneysen","year":"2010","journal-title":"Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.biocel.2021.106066_bib0290","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.tcm.2019.05.007","article-title":"The PCSK9 revolution: Current status, controversies, and future directions","volume":"30","author":"Warden","year":"2020","journal-title":"Trends Cardiovasc. Med."},{"issue":"5","key":"10.1016\/j.biocel.2021.106066_bib0295","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2337\/dc15-2439","article-title":"Cardiovascular risk factor targets and cardiovascular disease event risk in diabetes: a pooling project of the atherosclerosis risk in communities study, multi-ethnic study of atherosclerosis, and jackson heart study","volume":"39","author":"Wong","year":"2016","journal-title":"Diabetes Care."},{"issue":"10053","key":"10.1016\/j.biocel.2021.106066_bib0300","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Wong","year":"2016","journal-title":"Lancet."},{"issue":"7","key":"10.1016\/j.biocel.2021.106066_bib0305","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrcardio.2017.75","article-title":"Dyslipidaemia: PCSK9 inhibitors and foamy monocytes in familial hypercholesterolaemia","volume":"14","author":"Wu","year":"2017","journal-title":"Nature Rev. Cardio."},{"issue":"272","key":"10.1016\/j.biocel.2021.106066_bib0310","first-page":"pe7","article-title":"TRAF2: a double-edged sword?","author":"Xia","year":"2005","journal-title":"Sci. STKE"},{"issue":"1","key":"10.1016\/j.biocel.2021.106066_bib0315","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1038\/s41598-017-13072-1","article-title":"Danshenol A inhibits TNF-\u03b1-induced expression of intercellular adhesion molecule-1 (ICAM-1) mediated by NOX4 in endothelial cells","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci. Rep."}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272521001461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272521001461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:21:28Z","timestamp":1761204088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272521001461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":63,"alternative-id":["S1357272521001461"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2021.106066","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary hypercholesterolemia and development of cardiovascular disorders: Cellular and molecular mechanisms involved in low-grade systemic inflammation and endothelial dysfunction","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2021.106066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106066"}}